drugset / Trial / NCT00835952

ATX-101 Abdominoplasty

NCT00835952

Phase 1 Completed 14 enrolled Kythera Biopharmaceuticals
Non-randomizedSingle-groupOpen-labelBasic science

Summary

Histopathological study of abdominal fat excised from subjects undergoing abdominoplasty

Timeline

Start
2008-11
Primary completion
2009-03
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject ATX-101 Peptide Other

Indications

No indication recorded.